Page last updated: 2024-09-04

moxifloxacin and Libman-Sacks Disease

moxifloxacin has been researched along with Libman-Sacks Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Atsumi, T; Fujieda, Y; Iwasaki, N; Kamishima, T; Kono, M; Matsui, Y; Ninagawa, K1
Cao, J; Fan, L; He, F; Hu, K; Lei, M; Luo, Q; Qin, S; Shao, X; Yang, L; Yu, N1
Chen, W; He, X; Hong, T; Li, B; Liu, W; Qu, Q1
Agarwal, T; Jhanji, V; Sharma, N; Vajpayee, RB1

Reviews

1 review(s) available for moxifloxacin and Libman-Sacks Disease

ArticleYear
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
    Clinical rheumatology, 2020, Volume: 39, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Drug Combinations; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lopinavir; Lung; Lupus Erythematosus, Systemic; Moxifloxacin; Mycophenolic Acid; Pandemics; Pneumonia, Viral; Prednisone; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; RNA, Viral; SARS-CoV-2; Tomography, X-Ray Computed

2020

Other Studies

3 other study(ies) available for moxifloxacin and Libman-Sacks Disease

ArticleYear
Non-tuberculosis Mycobacterium Tenosynovitis with Rice Bodies in a Patient with Systemic Lupus Erythematosus.
    Internal medicine (Tokyo, Japan), 2020, Sep-15, Volume: 59, Issue:18

    Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Female; Fingers; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Moxifloxacin; Mycobacterium Infections; Symptom Flare Up; Tenosynovitis

2020
Successful treatment using corticosteroid combined antibiotic for acute acalculous cholecystitis patients with systemic lupus erythematosus.
    Medicine, 2017, Volume: 96, Issue:27

    Topics: Acalculous Cholecystitis; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Cholecystectomy; Conservative Treatment; Drug Therapy, Combination; Female; Fluoroquinolones; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Moxifloxacin; Treatment Outcome

2017
Presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis.
    Eye & contact lens, 2010, Volume: 36, Issue:6

    Topics: Adolescent; Aza Compounds; Cornea; Corneal Edema; Corneal Stroma; Corneal Transplantation; Drug Administration Schedule; Drug Therapy, Combination; Eyeglasses; Female; Fluoroquinolones; Glucocorticoids; Graft Rejection; Humans; Injections, Intravenous; Keratoconus; Lupus Erythematosus, Systemic; Methylprednisolone; Moxifloxacin; Ophthalmic Solutions; Postoperative Complications; Postoperative Period; Prednisolone; Quinolines; Time Factors; Ultrasonography; Visual Acuity

2010